The roles and regulation of TBX3 in development and disease

• Published in: Gene 2020-02, Vol.726, p.144223-144223, Article 144223
• Main Authors: Khan, Saif F., Damerell, Victoria, Omar, Rehana, Du Toit, Michelle, Khan, Mohsin, Maranyane, Hapiloe Mabaruti, Mlaza, Mihlali, Bleloch, Jenna, Bellis, Claire, Sahm, Bianca D.B., Peres, Jade, ArulJothi, K.N., Prince, Sharon
• Format: Article
• Language: English
• Subjects: Animals; Cancer; Cell Transformation, Neoplastic - genetics; Cell Transformation, Neoplastic - pathology; Co-factors; Disease - genetics; Gene Expression Regulation, Developmental - genetics; Heart development; Humans; Limb development; Lung development; Mammary gland development; Obesity; Rheumatoid arthritis; Signalling; Stem cells; T-Box Domain Proteins - genetics; T-box factors; Target genes; TBX3; Transcription factor; Transcription Factors - genetics; Ulnar mammary syndrome
• ISSN: 0378-1119; 1879-0038
• DOI: 10.1016/j.gene.2019.144223

TBX3, a member of the ancient and evolutionary conserved T-box transcription factor family, is a critical developmental regulator of several structures including the heart, mammary glands, limbs and lungs. Indeed, mutations in the human TBX3 lead to ulnar mammary syndrome which is characterized by several clinical malformations including hypoplasia of the mammary and apocrine glands, defects of the upper limb, areola, dental structures, heart and genitalia. In contrast, TBX3 has no known function in adult tissues but is frequently overexpressed in a wide range of epithelial and mesenchymal derived cancers. This overexpression greatly impacts several hallmarks of cancer including bypass of senescence, apoptosis and anoikis, promotion of proliferation, tumour formation, angiogenesis, invasion and metastatic capabilities as well as cancer stem cell expansion. The debilitating consequences of having too little or too much TBX3 suggest that its expression levels need to be tightly regulated. While we have a reasonable understanding of the mutations that result in low levels of functional TBX3 during development, very little is known about the factors responsible for the overexpression of TBX3 in cancer. Furthermore, given the plethora of oncogenic processes that TBX3 impacts, it must be regulating several target genes but to date only a few have been identified and characterised. Interestingly, while there is compelling evidence to support oncogenic roles for TBX3, a few studies have indicated that it may also have tumour suppressor functions in certain contexts. Together, the diverse functional elasticity of TBX3 in development and cancer is thought to involve, in part, the protein partners that it interacts with and this area of research has recently received some attention. This review provides an insight into the significance of TBX3 in development and cancer and identifies research gaps that need to be explored to shed more light on this transcription factor.